2 results
BIOENGINEERED CROPS AS TOOLS FOR INTERNATIONAL DEVELOPMENT: OPPORTUNITIES AND STRATEGIC CONSIDERATIONS
- PETER GREGORY, ROBERT H. POTTER, FRANK A. SHOTKOSKI, DESIREE HAUTEA, K. V. RAMAN, VIJAY VIJAYARAGHAVAN, WILLIAM H. LESSER, GEORGE NORTON, W. RONNIE COFFMAN
-
- Journal:
- Experimental Agriculture / Volume 44 / Issue 3 / July 2008
- Published online by Cambridge University Press:
- 01 July 2008, pp. 277-299
-
- Article
- Export citation
-
Crop bioengineering provides unique and dramatic opportunities for international agricultural development. However, we consider the technology not as a ‘silver bullet’ or panacea for crop improvement in the developing world but as an increasingly important tool that can be used to complement conventional methods of crop improvement. The number of bioengineered crops ready for commercial release in developing countries is expected to expand considerably in the next few years. But the multi-national life sciences companies that are leading the research, development and commercialization of bioengineered crops focus primarily on major crops that have high commercial value and extensive international markets. These companies also hold proprietary gene technology for many other crops of extreme importance to subsistence and resource-poor farmers but do not pursue product development and commercialization because of low anticipated returns. Such crops have traditionally been overlooked and are sometimes referred to as ‘orphan crops’ because of the relative lack of research and development applied to them. We propose a strategy for the development and delivery of bioengineered crops, including orphan crops, for developing countries. Consulting local public and private sector stakeholders to determine their highest priority needs for agricultural products is the first step. This ensures local stakeholder buy-in and that we do not invest in technology that is unlikely to be adopted. Next, the feasibility of developing and delivering the product is assessed. If the result is positive, the work is organized into ‘product commercialization packages’ (PCPs) that integrate all elements of the research, development and commercialization processes. The main elements of each PCP include (i) technology development; (ii) policy-related issues such as intellectual property and licensing, as well as gaining regulatory approval by the relevant national authorities; (iii) providing public information to producers and consumers about the benefits, risks and correct management of these new products; and (iv) establishing, or verifying, the existence of marketing and distribution mechanisms to provide farmers access to planting material. Our strategy involves integration of needs-based capacity building, socio-economic impact studies and product stewardship into each PCP. Whenever appropriate, opportunities are sought to create public–private partnerships to help leverage public funds, help absorb development costs and provide a broader distribution channel. To illustrate how our strategy is being translated into action we include, as a case study, examples of work by the US Agency for International Development-funded, Cornell University-led Agricultural Biotechnology Support Project II on the research, development and delivery of bioengineered fruit and shoot-borer-resistant eggplant varieties (Solanum melanogena) for South and Southeast Asia.
Prospects of fortification of salt with iron and iodine
- Bhattiprolu Sivakumar, G. N. V. Brahmam, K. Madhavan Nair, S. Ranganathan, M. Vishnuvardhan Rao, K. Vijayaraghavan, Kamala Krishnaswamy
-
- Journal:
- British Journal of Nutrition / Volume 85 / Issue S2 / May 2001
- Published online by Cambridge University Press:
- 09 March 2007, pp. S167-S173
- Print publication:
- May 2001
-
- Article
-
- You have access Access
- Export citation
-
Fortification of salt with iron has been developed by the National Institute of Nutrition (NIN) as a strategy for the control of iron deficiency anaemia (IDA) in India, similar to iodization of salt for control of iodine deficiency disorders (IDD). Stability of the iron fortified salt (IFS), its bioavailability and organoleptic evaluation of food items containing the IFS have been demonstrated. Acceptability and effectiveness of the IFS in school children and in multicentric community trials have been demonstrated. With the introduction of universal iodization of salt as a national policy in 1988, NIN has developed a formulation for double fortification (DFS) of salt with iodine and iron. The stability of the nutrients under laboratory conditions along with their bioavailability were found to be good but varying with the quality of salt used. The DFS has been evaluated in controlled trials in tribal communities and in residential school children. The findings of these studies are discussed. Overall, in these trials, DFS effectively controlled iodine deficiency but a clear impact on reducing anaemia was not demonstrated. In residential schoolchildren, increased urinary excretion of iodine as well as reduced anaemia were observed. The quality of salt has been found to be an important determinant of the stability of iodine in DFS. Further evaluation of this potentially important intervention is in progress.